Publication | Closed Access

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

VaccinationVaccine SafetyHealthy AdolescentsVaccine EfficacyInfection ControlVaccine HesitancyMedicineVaccine ResearchEpidemiology